Background illustration for clinical trials search

Paid Clinical Trials Morgantown

Discover 210 paid clinical trials in Morgantown, West Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for
Gastroesophageal-junction Cancer, Monoclonal Antibody,
Location: Morgantown WV, Pittsburgh PA, Cleveland OH, Sayre PA,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT06532006

Phase3, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

for
Hypoxic-Ischemic Encephalopathy
Location: Morgantown WV, Cleveland OH, Durham NC, Indianapolis IN,
Sponsor: ReAlta Life Sciences, Inc.

Sex: All

Age: 0

Code: NCT05778188

Phase2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Morgantown WV, Charlottesville VA, Vienna VA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

for
Respiratory Distress Syndrome, Pre-term Infants
Location: Morgantown WV, Charlottesville VA, Morristown NJ,
Sponsor: Aerogen Pharma Limited

Sex: All

Age: 0

Code: NCT06776783

Phase3, Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Location: Morgantown WV, Columbus OH, Baltimore MD, Cincinnati OH,
Sponsor: Beat AML, LLC

Sex: All

Age: 18+

Code: NCT03013998

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Morgantown WV, Rockville MD, Colombus OH, Columbus OH,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase2, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Morgantown WV, Charlottesville VA, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for
Endometrial Cancer, Malignant Solid Tumour
Location: Morgantown WV, Columbus OH, Cleveland OH, Fairfax VA,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07044336

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Morgantown WV, Smithfield PA, Manassas VA, Columbus OH,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Morgantown WV, Smithfield PA, Scottdale PA,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07082738

Phase2, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Morgantown WV, Pittsburgh PA, Silver Spring MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase3, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Morgantown WV, DuBois PA, Columbus OH, Columbia MD,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06883305

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Morgantown WV, Charleston WV, Frederick MD, Bethesda MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase3, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Morgantown WV, Kingwood WV, Smithfield PA, Scottdale PA,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase3, Recruiting

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

for
Maternal Complications, Pregnancy Complication,
Location: Morgantown WV
Sponsor: Jazz Pharmaceuticals

Sex: Female

Age: 0+

Code: NCT06113237

Recruiting

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

for
Myasthenia Gravis,
Location: Morgantown WV
Sponsor: argenx

Sex: Female

Age: 0+

Code: NCT06299748

Recruiting

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

for
Asthma
Location: Kingwood WV, Smithfield PA, Toledo OH, Philadelphia PA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06932263

Phase2, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for
Locally Advanced Urothelial Carcinoma,
Location: Uniontown PA, Washington PA, Jefferson Hills PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase3, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Uniontown PA, Mount Pleasant PA, Washington PA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase2, Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Uniontown PA, Washington PA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase3, Recruiting